News
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 and older, including death. Hotspots ranked Start the day smarter ☀️ ...
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health officials seek newer information on vaccine results in the global fight against ...
The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...
Senior doctors will be balloted on pay offer The BMA has announced indicative ballots of senior doctors in England, asking whether they are willing to take industrial action over their recent 4% pay ...
Hosted on MSN1mon
Valneva’s chikungunya vaccine use halted in older adults amid safety concerns - MSNIxchiq is a live, attenuated version of the virus administered as a single dose by injection. The vaccine may cause symptoms like those experienced by people who have chikungunya disease.
The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved by the Food and Drug Administration (FDA) in November 2023 as the first of its kind.
The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved by the Food and Drug Administration (FDA) in November 2023 as the first of its kind.
In addition to Brazil, IXCHIQ ® is approved for the prevention of disease caused by the chikungunya virus in people aged 12 years and older in the EU, and in people aged 18 years and older in the ...
Valneva (VALN) announced that the Brazilian Health Regulatory Agency has granted marketing authorization to its single-dose vaccine Ixchiq for the prevention of disease caused by the chikungunya ...
Hosted on MSN1mon
After 2 reported deaths, health officials tell Ixchiq users age 60+ to stop vaccine temporarily - MSNMay 12 (UPI) --U.S. health officials are advising patients using the drug Ixchiq to hold off while authorities seek newer information on vaccine results in the global fight against chikungunya.
May 12 (UPI) --U.S. health officials are advising patients using the drug Ixchiq to hold off while authorities seek newer information on vaccine results in the global fight against chikungunya.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results